1. Home
  2. CYTH vs SOS Comparison

CYTH vs SOS Comparison

Compare CYTH & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • SOS
  • Stock Information
  • Founded
  • CYTH 1990
  • SOS 2004
  • Country
  • CYTH United States
  • SOS China
  • Employees
  • CYTH N/A
  • SOS N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • SOS Finance: Consumer Services
  • Sector
  • CYTH Health Care
  • SOS Finance
  • Exchange
  • CYTH Nasdaq
  • SOS Nasdaq
  • Market Cap
  • CYTH 20.4M
  • SOS 21.0M
  • IPO Year
  • CYTH N/A
  • SOS 2017
  • Fundamental
  • Price
  • CYTH $0.63
  • SOS $7.10
  • Analyst Decision
  • CYTH Buy
  • SOS
  • Analyst Count
  • CYTH 3
  • SOS 0
  • Target Price
  • CYTH $0.95
  • SOS N/A
  • AVG Volume (30 Days)
  • CYTH 43.6K
  • SOS 464.2K
  • Earning Date
  • CYTH 11-14-2024
  • SOS 12-31-2024
  • Dividend Yield
  • CYTH N/A
  • SOS N/A
  • EPS Growth
  • CYTH N/A
  • SOS N/A
  • EPS
  • CYTH N/A
  • SOS N/A
  • Revenue
  • CYTH $870,725.00
  • SOS $111,124,000.00
  • Revenue This Year
  • CYTH N/A
  • SOS N/A
  • Revenue Next Year
  • CYTH $24.49
  • SOS N/A
  • P/E Ratio
  • CYTH N/A
  • SOS N/A
  • Revenue Growth
  • CYTH N/A
  • SOS N/A
  • 52 Week Low
  • CYTH $0.57
  • SOS $6.50
  • 52 Week High
  • CYTH $2.12
  • SOS $103.20
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 46.82
  • SOS 37.90
  • Support Level
  • CYTH $0.60
  • SOS $6.68
  • Resistance Level
  • CYTH $0.69
  • SOS $8.90
  • Average True Range (ATR)
  • CYTH 0.04
  • SOS 1.17
  • MACD
  • CYTH 0.00
  • SOS -0.14
  • Stochastic Oscillator
  • CYTH 50.00
  • SOS 9.98

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.

Share on Social Networks: